The serpins differ from the many other families of serine protease inhibitors in that they undergo a profound change in topology in order to entrap their target protease in an irreversible complex. The solving of the structure of this complex has now provided a video depiction of the changes involved. Cleavage of the exposed reactive centre of the serpin triggers an opening of the five-stranded A-sheet of the molecule, with insertion of the cleaved reactive loop as an additional strand in the centre of the sheet. The drastic displacement of the acyl-linked protease grossly disrupts its active site and gives an overall loss of 40% of ordered structure. This ability to provide effectively irreversible inhibition explains the selection of the serpins to control the proteolytic cascades of higher organisms. The conformational mechanism provides another advantage in its potential to modulate activity. Sequential crystallographic structures now provide clear depictions of the way antithrombin is activated on binding to the heparans of the microcirculation, and how evolution has utilized this mobile mechanism for subtle variations in activity. The complexity of these modulatory mechanisms is exemplified by heparin cofactor II, where the change in fold is seen to trigger multiple allosteric effects. The downside of the mobile mechanism of the serpins is their vulnerability to aberrant intermolecular ϐ-linkages, resulting in various disorders from cirrhosis to thrombosis. These provide a well defined structural prototype for the new entity of the conformational diseases, including the common dementias, as confirmed by the recent identification of the familial neuroserpin dementias.
Skip Nav Destination
Article navigation
September 2003
Issue Editors
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
Conference Article|
September 01 2003
How serpins change their fold for better and for worse
Robin W. Carrell;
Robin W. Carrell
1
1University of Cambridge, Department of Haematology, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 2XY, U.K.
1To whom correspondence should be addressed (e-mail [email protected]).
Search for other works by this author on:
James A. Huntington
James A. Huntington
1University of Cambridge, Department of Haematology, Wellcome Trust/MRC Building, Hills Road, Cambridge CB2 2XY, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1744-1439
Print ISSN: 0067-8694
© 2003 The Biochemical Society
2003
Biochem Soc Symp (2003) 70: 163–178.
Citation
Jeremy Saklatvala, Hideaki Nagase, Guy Salvesen, Robin W. Carrell, James A. Huntington; How serpins change their fold for better and for worse. Biochem Soc Symp 1 September 2003; 70 163–178. doi: https://doi.org/10.1042/bss0700163
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Related Articles
Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells
Biochem J (January,2000)
Identification of a novel targeting sequence for regulated secretion in the serine protease inhibitor neuroserpin
Biochem J (January,2007)
Molecular mousetraps and the serpinopathies
Biochem Soc Trans (April,2005)
α 1 -Antitrypsin deficiency, chronic obstructive pulmonary disease and the serpinopathies
Clin Sci (Lond) (May,2009)